Bio Green Med Solution (BGMS) Cash from Investing Activities (2010 - 2026)
Bio Green Med Solution (BGMS) posted quarterly Cash from Investing Activities of -$1000.0 for Q1 2026, up 83.33% quarter-over-quarter from -$6000.0 in Q1 2023.
Powered by 
Analysis
Bio Green Med Solution (BGMS) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Bio Green Med Solution (BGMS) has reported Cash from Investing Activities for 14 consecutive years, with -$1000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Investing Activities changed N/A year-over-year to -$1000.0; the TTM figure through Mar 2026 stood at -$1000.0 (changed N/A YoY), while the FY2023 annual figure was -$6000.0, up 14.29% from the prior year.
- Cash from Investing Activities rose to -$1000.0 in Q1 2026 per BGMS's latest filing, from -$6000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$1000.0 in Q1 2026 and bottomed at -$6000.0 in Q1 2023.
- Historically, Cash from Investing Activities has averaged -$3500.0 across 3 years, with a median of -$3500.0 in 2022.
- On a YoY basis, Cash from Investing Activities climbed as much as 94.87% in 2022 and fell as far as 104.84% in 2022.
- Bio Green Med Solution's Cash from Investing Activities stood at -$3000.0 in 2022, then sank by 100.0% to -$6000.0 in 2023, then surged by 83.33% to -$1000.0 in 2026.
- Business Quant data shows BGMS's Cash from Investing Activities at -$1000.0 in Q1 2026, -$6000.0 in Q1 2023, and -$3000.0 in Q2 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.34 Bn | 133.48 Bn | 2.84 Bn | -45.80 Mn |
| 2 | Regeneron Pharmaceuticals | 86.40 Bn | 78.41 Bn | 3.93 Bn | -92.70 Mn |
| 3 | Argenx Se | 64.65 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.60 Bn | 53.47 Bn | 52.00 Mn | 329.00 Mn |
| 5 | Revolution Medicines | 44.47 Bn | 44.47 Bn | - | -1.66 Bn |
| 6 | BeOne Medicines | 40.34 Bn | 35.24 Bn | 1.53 Bn | -49.35 Mn |
| 7 | Alnylam Pharmaceuticals | 35.02 Bn | 31.72 Bn | 992.69 Mn | -363.46 Mn |
| 8 | Royalty Pharma | 28.34 Bn | 27.50 Bn | - | -229.72 Mn |
| 9 | Insmed | 27.22 Bn | 26.06 Bn | 358.27 Mn | 24.51 Mn |
| 10 | Bio Green Med Solution | 5.21 Mn | 1.42 Mn | 79,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -1,000.00 |
| Mar 31, 2023 | -6,000.00 |
| Jun 30, 2022 | -3,000.00 |
| Mar 31, 2022 | -4,000.00 |
| Dec 31, 2021 | -2,000.00 |
| Sep 30, 2021 | -9,000.00 |
| Jun 30, 2021 | 62,000.00 |
| Mar 31, 2021 | -78,000.00 |
| Dec 31, 2020 | -42,000.00 |
| Sep 30, 2020 | -50,000.00 |
| Mar 31, 2020 | -4,000.00 |
| Dec 31, 2019 | 6,000.00 |
| Sep 30, 2019 | -4,000.00 |
| Jun 30, 2019 | -1,000.00 |
| Mar 31, 2019 | 27,000.00 |
| Dec 31, 2018 | -6,000.00 |
| Sep 30, 2018 | -2,000.00 |
| Jun 30, 2018 | -9,000.00 |
| Mar 31, 2018 | -22,000.00 |
| Dec 31, 2017 | -2,000.00 |